Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- The Allergan-Medicis Vanity Pharma Death Match Is About to Get Complicated
- Imagine your drug company has the following problems: A portfolio of expensive, discretionary cosmetic products that Medicare and Medicaid won't reimburse for; it's under investigation by the Department of Justice for alleged off-label promotion; the recession is crimping consumers' desire to spend money on non-essential drug products;...
- Blog posts 2008-09-08
- Medicis' Accounting Error Puts Spotlight on Solodyn Weakness; Allergan Rejoices
- Medicis stock tumbled roughly 16 percent yesterday after it announced that it would restate six years of its numbers due to an accounting error. But the magnitude of the fall seems to have drawn attention not to the vanity pharma company's inability to count beans, but the...
- Blog posts 2008-09-25
- Q&A With Medicis CEO Jonah Shacknai, Who Sees a "Definite Downturn" in Vanity Pharma
- Medicis is going through a dramatic period. The vanity pharma company's Restylane dermal filler is in a battle royale with Allergan's Juvederm. It's waiting for FDA approval for Reloxin, its competitor to Allergan's Botox. And it just acquired LipoSonix, a high-intensity non-invasive ultrasound fat reducer. I talked...
- Blog posts 2008-10-06
- Medicis Explains Sudden Increase in Company's Deferred Tax Assets
- A while ago, Medicis restated its numbers going back several quarters due to an accounting error. The mistake involved the company's "sales return reserve," a technical line on the company's financial statements that few understand. Medicis has since filed new statements and they contain a surprise: A massive accumulation of...
- Blog posts 2008-12-04
- Medicis Solves One Solodyn Problem But Barr Pops Up With Another
- Barr Pharmaceuticals has filed to make a generic version of Medicis's acne drug, Solodyn. Medicis stock had received a nice boost at the beginning of December when it announced an unexpected deal with a different company, Impax, over generic versions of Solodyn. The deal meant Medicis would...
- Blog posts 2008-12-30
- Medicis' Solodyn Sales Stay Strong Despite Generic Challenges; Pay-to-Delay Works
- Despite both Teva and Sandoz dipping their generic toes into the Solodyn acne franchise, sales of Medicis' pimple-popper are still going up. Why? Because Medicis has paid most of those rivals to stop making their versions of the drug. by Jim Edwards
- Blog posts 2009-09-29
- Medicis' Liposonix Launch Eyed for 2011; Ultrasound Device Will "Melt" Away Fat
- Medicis' Liposonix, a non-invasive fat-removing device, "should be enormous," according to Jefferies & Co. analysts Corey Davis and Oren G. Livnat, writing in a note to investors. Liposonix won't be launched until 2011. by Jim Edwards
- Blog posts 2009-10-02
Additional Resources
- Medicis Doubled Pay of Exec Convicted of Off-Label Sales
- Medicis more than doubled the pay of its sales chief in 2008 even though that executive, Richard Havens, pled guilty to conspiracy to violate the Food and Drug Act last March. Havens, the former evp of sales, and three of his underlings pleaded guilty right before his April retirement to...
- Blog posts 2009-04-08
- Medicis Employees Should Look Anxiously at Allergan Layoffs
- Sales reps at Restylane-maker Medicis should look anxiously at Allergan's announcement that its earnings and revenues are down. Allergan announced a "restructuring" to deal with the downturn -- that means 460 employees will get the ax, the company said. What does this have to do with Medicis?...
- Blog posts 2009-02-05
- Medicis Board Unanimously Rejects Mentor Proposal
- SCOTTSDALE, Ariz. -- The Board of Directors of Medicis (NYSE:MRX) has unanimously rejected an unsolicited proposal by Mentor Corporation (NYSE:MNT) to acquire Medicis by exchanging 0.62 of a share of Mentor for each share of Medicis. The Medicis Board confirmed that Medicis remains committed to completing its proposed merger with...
- Research articles 2005-11-20
- Medicis Squeezed in Vanity Pharma Death Match vs. Allergan and J&J
- Medicis may find itself on the losing side of the vanity pharma death match now that Johnson & Johnson has waded in with what will soon be a full suite of silicone breast implants, wrinkle fillers and botulinum toxin line smoothers. J&J on Monday agreed to acquire implant maker Mentor...
- Blog posts 2008-12-02
- District Court Affirms Dismissal of Prasco's Declaratory Judgment Suit Against Medicis
- Aaron F. Barkoff submits: Prasco v. Medicis Pharm. Corp., No. 2007-1524 (Fed. Cir. 2008) Medicis markets a benzoyl peroxide cleansing product, Triaz. Prasco sells a competing benzoyl peroxide cleansing product, Oscion. Prasco filed a declaratory judgment complaint, requesting judgment that Oscion does not infringe four patents owned or licensed by Medicis...
- External links 2008-10-07
- Medicis to Present at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
- SCOTTSDALE, Ariz. -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Morgan Stanley Pharmaceutical CEOs Unplugged Conference in New York. A live webcast of its presentation scheduled for Thursday, January 6, 2004, at 6:30 a.m. Pacific Time (9:30 a.m. Eastern Time), may be accessed via...
- Research articles 2004-12-30
- Medicis to Present at 23rd Annual JPMorgan Healthcare Conference
- SCOTTSDALE, Ariz. -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the 23rd Annual JPMorgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco. A live webcast of its presentation scheduled for Tuesday, January 11, 2005, at 10:30 a.m. Pacific Time (1:30 p.m. Eastern...
- Research articles 2005-01-06
- Medicis to Present at Merrill Lynch 16th Annual Global Pharmaceutical, Biotechnology & Medical Device Conference
- SCOTTSDALE, Ariz. -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Merrill Lynch 16th Annual Global Pharmaceutical, Biotechnology & Medical Device Conference at The Grand Hyatt in New York. A live webcast of its presentation scheduled for Thursday, February 10, 2005, at 10:30 a.m. Eastern...
- Research articles 2005-02-07
- Medicis to Present at Morgan Stanley 3rd Annual Healthcare Unplugged Conference
- SCOTTSDALE, Ariz. -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Morgan Stanley 3rd Annual Healthcare Unplugged Conference in Miami, Florida. A live webcast of its presentation scheduled for Thursday, May 5, 2005, at 11:15 a.m. Eastern Time (8:15 a.m. Pacific Time), may be accessed...
- Research articles 2005-05-02
- Medicis to Present at Banc of America Securities 2005 Specialty Pharmaceuticals Conference
- SCOTTSDALE, Ariz. -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Banc of America Securities 2005 Specialty Pharmaceuticals Conference at The Southampton Inn in Southampton, New York. This year's conference theme is "New Products, New Paradigms." A live webcast of Medicis' presentation, scheduled for Thursday,...
- Research articles 2005-07-25
- US FTC approves Medicis' acquisition of HA North American Sales AB
- NORDIC BUSINESS REPORT-5 March 2003-US FTC approves Medicis' acquisition of HA North American Sales ABC1994-2003 M2 COMMUNICATIONS LTD http://www.m2.com The Swedish biotech company Q-Med AB said today (5 March) that the US Federal Trade Commission had approved the pharmaceuticals company Medicis' acquisition of Q-Med's subsidiary HA North American Sales...
- Research articles 2003-03-05
- Medicis to Present at 24th Annual JPMorgan Healthcare Conference
- SCOTTSDALE, Ariz. -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the 24th Annual JPMorgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco. A live webcast of its presentation scheduled for Tuesday, January 10, 2006, at 10:30 a.m. Pacific Time (1:30 p.m. Eastern...
- Research articles 2006-01-06
- Medicis to Present at JP Morgan 21st Annual Healthcare Conference
- Business Editors, Pharmaceutical Writers SCOTTSDALE, Ariz.--BUSINESS WIRE--Dec. 30, 2002 Medicis (NYSE:MRX) today announced that a live webcast of its presentation scheduled for Monday, January 6, 2003, at 10 a.m. Pacific Time (1 p.m. Eastern Time), may be accessed via the Internet. Medicis is scheduled to present at...
- Research articles 2002-12-30
- << Previous
- page 1 of 1
- Next >>
